Литература
1. Бокерия О.Л., Кудзоева З.Ф., Канаметов ТН.
Оптимальная медикаментозная терапия больных
со стабильной ишемической болезнью
сердца и после операции реваскуляризации
миокарда. Бюллетень НЦССХ им. А.Н. Бакулева
РАМН. 2015; 16 (4): 4-16.
2. Reyes G., Allen K.B., Alvarez P., Alegre A.,
Aguado B., Olivera M. et al. Mid term results after
bone marrow laser revascularization for treating
refractory angina. BMC Cardiovasc. Dis. 2010; 10:42
http://www.biomedcentral.com/1471-2261/10/42.
DOI: 10.1186/1471-2261-10-42.
3. Janusz K.K., Pi^tek J., Miszalski-Jamka T,
Rudzinnski P., Zbigniew W, Bartus K. et al. The
combined use of trans myocardial laser revascularization
and intramyocardial injection of bone-marrow
derived stem cells in patients with end-stage coronary
artery disease: one year follow-up. Kardiol. Pol. 2013;
71, 5: 485-492; DOI: 10.5603/KP.2013.0095
4. Панченко В.Я., Васильцов В.В., Ульянов В.А.
Лазерный метод ТМЛР-лечения ишемической
болезни сердца. Фотоника. 2012; 1(31): 14-9.
5. Sen P., Udwadia T, Kinare S., Parulkar G. Transmyocardial
revascularization: a new approach to
myocardial revascularization. J. Thorac. Cardiovasc.
Surg. 1965; 50: 181-9.
6. Pifarre R., Jasuja M., Lynch R., Neville W
Myocardial revascularization by transmyocardial
acupuncture: a physiologic impossibility. J. Thorac.
Cardiovasc. Surg. 1969; 58: 424-31.
7. Mirhoseini M., Cayton M.M. Revascularization of
the heart by laser. J. Microsurg. 1981; 2: 253-60.
8. Mirhoseini M. Laser applications in thoracic and
cardiovascular surgery. Med. Instrum. 1983; 17(6):
401-3.
9. Huikeshoven M., Beek J.F., van der Sloot J.A.P.,
Tukkie R., van der Meulen J., van Gemert M.J.C.
35 years of experimental research in transmyocardial
revascularization: What have we learned? Ann.
Thorac. Surg. 2002; 74: 956-70.
10. Malekan R., Reynolds C., Narula N., Kelley S.T.,
Suzuki Y., Bridges C.R. Angiogenesis in transmyocardial
laser revascularization-a nonspecific
response to injury. Circulation. 1998; 98 (2): 62-5.
11. Kornowski R., Epstein S.E., Leon M.B. Handbook
of myocardial revascularization and angiogenesis.
London: Martin Dunitz; 2000.
12. Shawl F.A., Kaul U., Saadat V. Percutaneous myocardial
revascularization using a myocardial channeling
device: first human experience using the AngioTrax
system. J. Am. Coll. Cardiol. 2000; 35: 61A.
13. Smith N.B., Hynynen K. The feasibility of using
focused ultrasound for transmyocardial revascularization.
Ultrasound Med. Biol. 1998; 24: 1045-54.
14. Khairy P., Dubuc M., Gallo R. Cryoapplication
induces neovascularization: a novel approach to
percutaneous myocardial revascularization. J. Am.
Coll. Cardiol. 2000; 35: 5A-6A.
15. Dietz U., Darius H., Eick O., Buerke M.,
El Odeh R. Transmyocardial revascularisation using
temperature controlled HF energy creates reproducible
intramyocardial channels. Circulation.
1998; 98: 3770.
16. Yamamoto N., Gu A.G., Derosa C.M. et al. Radio
frequency transmyocardial revascularization
enhances angiogenesis and causes myocardial denervation
in a canine model. Lasers Surg. Med. 2000;
27: 18-28.
17. Spaulding C.M., Souza L.C.G., Richard P.,
Pouzet B., Bowden R., Faas B. et al. Percutaneous
myocardial revascularization with a newly developed
high pressure saline-jet system evaluation of
acute and chronic effects in porcine hearts. J. Am.
Coll. Cardiol. 2001. 37 (2 Suppl.): 48a, Ruary.
18. Estvold S.K., Mordini F., Zhou Y., Zx Y.,
Sachdev V., Arai A., Horvath K.A. Does laser type
impact myocardial function following transmyocardial
laser revascularization? Lasers Surg. Med. 2010;
42(10): 746-51. DOI:10.1002/lsm.21012
19. Fisher E.P., Khomoto T, De Rosa M.C.,
Spotnitz H.M., Smith C.R., Burkhoff D. Histologic
analysis of transmyocardial channels: Comparison
of CO2 and holmium: YAG Lasers. Ann. Thorac.
Surg. 12997; 64: 466-72.
20. Huikeshoven M., Belien J.A., Tukkie R., Beek J.F.
The vascular response induced by transmyocardial
laser revascularization is determined by the size of
the channel scar: Results of CO2, holmium and
excimer lasers. Lasers Surg. Med. 2004; 35(1):
35-40. DOI: 10.1002/lsm.20070
21. Frazier O.H., March R.J., Horvath K.A. Transmyocardial
revascularization with a carbon dioxide
laser in patients with end-stage coronary artery disease.
N. Engl. J. Med. 1999; 341: 1021-8.
22. Schofield P.M., Sharples L.D., Caine N., Burns S.,
Tait S., Wistow T. et al. Transmyocardial laser revascularization
in patients with refractory angina:
a randomized controlled trial. Lancet. 1999; 353:
519-24.
23. Aaberge L., Nordstrand K., Dragsund M. et al.
Transmyocardial revascularization with CO2 laser in
patients with refractory angina pectoris. Clinical
results from the Norwegian randomized trial. J. Am.
Coll. Cardiol. 2000; 35: 1170-7.
24. Aaberge L., Rootwelt K., Blomhoff S., Saatvedt K.,
Abdelnoor M., Forfang K. Continued symptomatic
improvement three to five years after transmyocardial
revascularization with CO2 laser: a late clinical
follow-up of the Norwegian randomized trial with
transmyocardial revascularization. J. Am. Coll.
Cardiol. 2002; 39: 1588-93.
25. Allen K.B., Dowling R.D., Fudge T.L., Schoettle
G.P., Selinger S.L., Gangahar D.M. et al.
Comparison of transmyocardial revascularization
with medical therapy in patients with refractory
angina. N. Engl. J. Med. 1999; 341: 1029-36. DOI:
10.1056/NEJM199909303411403
26. Burkhoff D., Schmidt S., Schulman S.P., Myers J.,
Resar J., Becker L.C. et al. Transmyocardial laser
revascularization compared with continued medical
therapy for treatment of refractory angina pectoris:
a prospective randomized trial. Lancet. 1999; 354:
885-90.
27. Whittaker P., Abela G.S. Direct myocardial revascularization:
history, methodology, technology.
Boston: Kluwer Academic; 1999.
28. Klein M., Schulte H.D., Gams E. Transmyocardial
laser revascularisation: management of coronary
artery diseases. Berlin: Springer; 1998. DOI
10.1007/978-3-642-72134-2
29. Okada M. (Ed.). Current topics in transmyocardial
laser revascularization. Tokyo, Japan: Medical
Tribune Inc:, 2001.
30. Tavris D.R., Brennan J.M., Sedrakyan A., Zhao Y.,
O'Brien S.M., Peterson E.D. et al. Long-term outcomes
after transmyocardial revascularization. Ann.
Thorac. Surg. 2012; 94 (5): 1500-08. DOI:
10.1016/j.athoracsur.2012.05.068.
31. Bridges C.R., Horvath K.A., Nugent W.C. The
Society of Thoracic Surgeons Practice Guideline
Series: Transmyocardial laser revascularization.
Ann. Thorac. Surg. 2004; 77: 1494-1502. DOI:
http://dx.doi.org/10.1016/j.athoracsur.2004.01.007
32. Бокерия Л.А., Беришвили И.И., Вахромеева
М.Н., Хвичия Л.Э., Игнатьева Ю.В., Гусев
П.В. Сравнительная оценка результатов хирургического
лечения больных ишемической
болезнью сердца с помощью АКШ в сочетании
с ТМЛР и без нее. Анналы хирургии. 2012; (4):
34-40.
33. Бокерия Л.А., Бокерия О.Л., Рубцов П.П., Са-
накоев М.К. Случай хирургической коррекции
аномалии Эбштейна с созданием неосепталь-
ной створки из ткани правого предсердия. Бюллетень
НЦССХ им. А.Н. Бакулева РАМН. 2013;
14 (4): 67-71.
34. Бокерия Л.А., Донаканян С.А. Перспективы
применения стволовых клеток в лечении многососудистого
поражения коронарных артерий.
Бюллетень НЦССХ им. А.Н. Бакулева РАМН.
2013; 14(6): 20-9.
35. Bockeria L.A., Bogin V., Bockeria O.L., Le T.,
Alekyan B.G., Woods E.J. et al. Endometrial regenerative
cells for treatment of heart failure: a new
stem cell enters the clinic. J. Transl. Med. 2013;
11:56. DOI: 10.1186/1479-5876-11-56
36. Vrtovec B., Poglajen G., Lezaic L., Sever M.,
Domanovic D., Cernelc P. et al. Effects of intracoronary
CD34+ stem cell transplantation in nonischemic
dilated cardiomyopathy patients: 5-year
follow-up. Circ. Res. 2013; 112 (1): 165-73.
37. Vrtovec B., Poglajen G., Sever M., Lezaic L.,
Domanovic D., Cernelc P. et al. Effects of intracoronary
stem cell transplantation in patients with
dilated cardiomyopathy. J. Card. Fail. 2011; 17(4):
272-8.
38. Hare J.M., Fishman J.E., Gerstenblith G. et al.
Comparison of allogeneic vs autologous bone marrow-
derived mesenchymal stem cells delivered by
transendocardial injection in patients with ischemic
cardiomyopathy. The POSEIDON Randomized
Trial. JAMA. 2012; 12 (22): 2369. DOI:
10.1001/jama.2012.25321
39. Zhuo Y., Li S.H., Chen M.S. et al. Aging impairs
the angiogenic response to ischemic injury and the
activity of implanted cells: combined consequences
for cell therapy in older recipients. J. Thorac.
Cardiovasc. Surg. 2010; 139 (5): 1286-1294, 1294,
e1-e2. DOI: 10.1016/j.jtcvs.2009.08.052
40. Kinkaid H.Y., Huang X.P., Li R.K., Weisel R.D.
What's new in cardiac cell therapy? Allogeneic bone
marrow stromal cells as “universal donor cells.”
J. Card. Surg. 2010; 25 (3): 359-66. DOI:
10.1111/j.1540-8191.2009.00984.x
41. Van Ramshorst J., Bax J.J., Beeres A., L.M. Saskia,
Dibbets-Schneider P., Roes S.D., Stokkel M.P.M.
et al. Intramyocardial bone marrow cell injection
for chronic myocardial ischemia a randomized controlled
trial. JAMA. 2009; 301 (19): 1997-2004.
42. Abdel-Latif A., Bolli R., Tleyjeh I.M., Montori
V.M., Perin E.C., Hornung C.A. et al. Adult
bone marrow-derived cells for cardiac repair a systematic
review and meta-analysis. Arch. Intern.
Med. 2007; 167: 989-997. DOI: 10.1001/archinte.
167.10.989
43. Schachinger V., Erbs S., Elsasser A., Haberbosch
W, Hambrecht R., Holschermann H. et al.
REPAIR-AMI Investigators. Intracoronary bone
marrow-derived progenitor cells in acute myocardial
infarction. N. Engl. J. Med. 2006; 355 (12):
1210-21. DOI: 10.1056/NEJMoa060186
44. Assmus B., Leistner D.M., Schachinger V.,
Erbs S., Elsasser A., Haberbosch W. et al. The
REPAIR-AMI Study Group. Long-term clinical
outcome after intracoronary application of bone
marrow-derived mononuclear cells for acute
myocardial infarction: migratory capacity of
administered cells determines event-free survival.
Eur. Heart J. 2014; 35: 1275-83. DOI:
10.1093/eurheartj/ehu062
45. Strauer B.E., Yousef M., Schannwell C.M. The
acute and long-term effects of intracoronary Stem
cell Transplantation in 191 patients with chronic
heARt failure: the STAR-heart study. Eur. J. Heart
Fail. 2010; 12: 721-9 DOI:10.1093/eurjhf/hfq095.